HRQOL in Prostate Cancer Patients Treated With Radiotherapy

The study primarily aims at evaluating health-related quality of life after radiotherapy for prostate cancer, using modern hypofractionated radiotherapy schedules. Study design is a prospective observational cohort study. All patients give written informed consent and fill out online validated questionnaires before, during, and after radiotherapy (yearly) up to 5 years post-treatment.

Inclusion Criteria:Clinically T1c-T4, N0 (or N+ in case of EBRT-LN+), M0 prostate cancer patient referred for radiotherapy.Willing and capable to fill out Dutch questionnaires on health-related items at a computer (online questionnaires).Signed written Informed Consent.Exclusion Criteria:Previously radiation treatment in the pelvic region, for any reason.Diagnosed with other tumor in the past 12 months or known with tumor progression of another tumor.Postoperative radiotherapy with dose levels < 72 Gy.